Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
26.05
-1.95 (-6.96%)
At close: Nov 20, 2024, 4:00 PM
26.51
+0.46 (1.77%)
Pre-market: Nov 21, 2024, 7:04 AM EST
Cassava Sciences Employees
Cassava Sciences had 29 employees as of December 31, 2023. The number of employees increased by 3 or 11.54% compared to the previous year.
Employees
29
Change (1Y)
3
Growth (1Y)
11.54%
Revenue / Employee
n/a
Profits / Employee
-$609,103
Market Cap
1.25B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
MiMedx Group | 895 |
Schrödinger | 867 |
Arcus Biosciences | 577 |
Harrow | 315 |
Ocular Therapeutix | 267 |
Syndax Pharmaceuticals | 184 |
Praxis Precision Medicines | 82 |
SAVA News
- 3 days ago - Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer - GlobeNewsWire
- 10 days ago - Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease - Seeking Alpha
- 13 days ago - Cassava Sciences, Inc. (SAVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Cassava Sciences Reports Q3 2024 Financial and Operating Results - GlobeNewsWire
- 21 days ago - Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 - GlobeNewsWire
- 6 weeks ago - What's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday? - Benzinga
- 7 weeks ago - Cassava's Stock Drops After It Agrees to Pay $40M to Settle SEC Alzheimer's Claims - Investopedia
- 7 weeks ago - SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty - Benzinga